• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAdlai Nortye
    Picture of Adlai Nortye logo

    ANL — Adlai Nortye News Story

    $12.090.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    • Market Cap
      $641.70m
    • Enterprise Value
      $435.59m
    • Revenue
      $5.00m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ANL Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ANL Dividends
    All News

    NASDAQ RESUMED AT 10:42 AM

    Picture of Adlai Nortye logoAdlai Nortye
    15/04/2026 15:42
    NASDAQ RESUMED  ANL.O  AT 10:42 AM
    

    Recent news on Adlai Nortye

    See all news
    • Advisory: Alerts wrongly tagged to Merck & Co withdrawn

      15/10/2026 12:14
    • Brief: Adlai Nortye Appoints Christopher Liu, Pharmd, As Head Of Investor Relations And Public Relations

      30/09/2026 12:10
    • Brief: Adlai Nortye Announces Clinical Trial Notification Submission And Hrec Approval

      03/08/2026 14:22
    • Brief: Adlai Nortye Files For Mixed Shelf Offering Of Up To $600 Million

      23/04/2026 11:37
    • U.S. STOCKS ON THE MOVE-Netflix, J.B. Hunt, Arxis

      16/04/2026 18:45

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.